BioMarin Pharmaceutical

Latest clinical program signals indexed for BioMarin Pharmaceutical.

1. VABIOTECH-01 — Unknown

   Jun 8, 2026
   Clinical update →

2. Tuberculosis Vaccine — Phase 1

   Jun 8, 2026
   Clinical update →

3. Taneasy 600mg granules — Approved

   Jun 8, 2026
   Clinical update →

4. SARS-CoV-2 mRNA Vaccine — Phase 3

   Jun 8, 2026
   Clinical update →

5. rhGM-CSF group — Approved

   Jun 8, 2026
   Clinical update →

6. Recombinant Human VEGF Receptor-Fc Fusion Protein — Phase 3

   Jun 8, 2026
   Clinical update →

7. Pegfilgrastim — Phase 1

   Jun 8, 2026
   Clinical update →

8. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV — Phase 3

   Jun 8, 2026
   Clinical update →

1. NCT00103389

   PI-88

   Phase 2 · completed · small_molecule

   Lung Cancer

   CT.gov ↗
2. NCT00685698

   TG-873870 (Nemonoxacin)

   Phase 2 · completed · small_molecule

   Diabetic Foot Infections

   CT.gov ↗
3. NCT00985998

   Nimotuzumab and chemotherapy

   Phase 1 · terminated · small_molecule

   Non-small Cell Lung Cancer

   CT.gov ↗
4. NCT01116778

   eN-Lac®

   Phase 3 · completed · mab

   Perennial Allergic Rhinitis

   CT.gov ↗
5. NCT01232504

   rhGM-CSF group

   Approved · completed · small_molecule

   Mycoses

   CT.gov ↗
6. NCT01436864

   Recombinant Human VEGF Receptor-Fc Fusion Protein

   Phase 3 · completed · mab

   Neovascular Age-related Macular Degeneration

   CT.gov ↗
7. NCT02034669

   Laminectomy

   Phase 2 · active · other

   Acute Spinal Cord Injury

   CT.gov ↗
8. NCT02063607

   Peginterferon lambda

   Phase 1 · completed · mab

   Hepatitis C

   CT.gov ↗
9. NCT02085395

   SR-T100 ® Gel

   Phase 2 · completed · small_molecule

   Actinic Keratosis

   CT.gov ↗
10. NCT02249650

    TSB-9-W1

    Phase 1 · completed · small_molecule

    Metastatic Colorectal Cancer

    CT.gov ↗
11. NCT02313233

    Umooze

    Unknown · completed · other

    Benign Prostatic Hyperplasia

    CT.gov ↗
12. NCT02395068

    Nimotuzumab

    Phase 1 · active · small_molecule

    Solid Tumors

    CT.gov ↗
13. NCT02994147

    Placebo

    Phase 2 · completed · small_molecule

    Hemophilic Arthropathy

    CT.gov ↗
14. NCT03020823

    SCB01A

    Phase 2 · terminated · small_molecule

    Head and Neck Neoplasms

    CT.gov ↗
15. NCT03130829

    Oligo Fucoidan

    Unknown · terminated · other

    NSCLC Stage IV

    CT.gov ↗
16. NCT03376503

    Pegfilgrastim

    Phase 1 · completed · small_molecule

    Breast Cancer

    CT.gov ↗
17. NCT03381417

    pegcyte

    Phase 3 · completed · small_molecule

    Breast Cancer Female

    CT.gov ↗
18. NCT03583164

    Olorofim

    Phase 2 · completed · small_molecule

    Invasive Fungal Infections

    CT.gov ↗
19. NCT03790891

    CD19-TriCAR-T/SILK

    Phase 1 · active · mab

    Non-Hodgkin Lymphoma

    CT.gov ↗
20. NCT03931239

    VABIOTECH-01

    Unknown · completed · mab

    Diphtheria

    CT.gov ↗
21. NCT04847102

    SARS-CoV-2 mRNA Vaccine

    Phase 3 · active · mab

    COVID-19

    CT.gov ↗
22. NCT04922788

    Nanocovax

    Phase 3 · completed · mab

    SARS-CoV-2 Infection

    CT.gov ↗
23. NCT05101187

    Olorofim

    Phase 3 · active · small_molecule

    Invasive Aspergillosis

    CT.gov ↗
24. NCT05301010

    Faceptor

    Phase 3 · completed · small_molecule

    Breast Cancer Metastatic

    CT.gov ↗
25. NCT05301530

    Faceptor

    Phase 3 · completed · small_molecule

    Breast Cancer Metastatic

    CT.gov ↗
26. NCT05486728

    SHJ002/Vehicle

    Phase 2 · completed · small_molecule

    Dry Eye Disease

    CT.gov ↗
27. NCT05585645

    Stimus (NNG-DEPO)

    Phase 3 · completed · mab

    Anemia

    CT.gov ↗
28. NCT05639998

    COVAXIN(BBV152)

    Phase 2 · completed · mab

    Corona Virus Infection

    CT.gov ↗
29. NCT05737355

    ANKASCIN 568-P Red yeast rice capsules

    Unknown · active · other

    Hyperlipidemias

    CT.gov ↗
30. NCT05770882

    Chidamide

    Phase 2 · terminated · small_molecule

    Hepatocellular Carcinoma (HCC)

    CT.gov ↗
31. NCT05833724

    Chidamide

    Phase 2 · active · small_molecule

    Relapsed or Refractory Peripheral T-cell Lymphoma

    CT.gov ↗
32. NCT05934890

    Walvax PCV13-TT

    Phase 3 · active · mab

    Pneumococcal Disease, Invasive

    CT.gov ↗
33. NCT05999955

    Neomycin/ Dexameythasone/Xylometazoline

    Unknown · completed · small_molecule

    Rhinosinusitis

    CT.gov ↗
34. NCT06438978

    Tuberculosis Vaccine

    Phase 1 · completed · mab

    Tuberculosis

    CT.gov ↗
35. NCT06466525

    LBT-3627

    Phase 1 · active · small_molecule

    Parkinson Disease

    CT.gov ↗
36. NCT06828120

    Taneasy 600mg granules

    Approved · completed · small_molecule

    COPD (Chronic Obstructive Pulmonary Disease)

    CT.gov ↗
37. NCT06907875

    EPI-321

    Phase 2 · active · mab

    Facioscapulohumeral Muscular Dystrophy

    CT.gov ↗
38. NCT06968299

    ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules

    Unknown · active · other

    Cognitive Functions Perceptual Disturbances

    CT.gov ↗
39. NCT07211152

    Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Phase 3 · active · mab

    Influenza

    CT.gov ↗
40. NCT07457060

    2wIPV+1sIPV

    Approved · active · mab

    Poliomyelitis

    CT.gov ↗
41. NCT07532837

    Lactobacillus rhamnosus F-1

    Unknown · active · other

    Allergic Rhinitis

    CT.gov ↗